New York, NY, United States of America

Drug Delivery Systems Inc.


USPTO Granted Patents = 40

Forward Citations = 2,525

Loading Chart...
Loading Chart...

4 inventors (with patents filed for the assignee):

goldMedal Dan Sibalis (39 out of 47 patents)

silverMedal Sanford Rosen (6 out of 7 patents)

bronzeMedal Gilad Lavi (1 out of 45 patents)

4.  Joseph Gross (1 out of 77 patents)


Core Competencies:
Transdermal Drug Applicator
Pulsating Delivery System
Programmable Control
Electrophoretic Delivery
Disposable Applicators
Electrical Transdermal Delivery
Conductive Fibers
Electrokinetic Techniques
Multi-Signal Electrical
Non-Invasive Delivery
Polypeptides Delivery

40 patents:

Company Overview
Drug Delivery Systems Inc., based in New York, specializes in innovative drug delivery technologies. The company focuses on transdermal and iontophoretic drug delivery systems, developing advanced programmable control systems and various drug applicators. Their expertise extends to electrolytic and pulsating drug delivery methods, as well as the design of disposable and electrical drug applicators. By leveraging these technologies, Drug Delivery Systems Inc. aims to enhance the efficacy and convenience of medication administration for patients.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

40 Patents

#230 in New York, NY

#532 in New York

#8,628 in US

#17,068 in the World

New York, NY (US)
New York, NY, United States of America
Forward Citations = 2,525

4 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Drug Delivery Systems Inc.. Retrieved from https://idiyas.com/company/drug-delivery-systems

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…